Save your place

Sign in to WhoBought

Please try again later.

PDS Biotechnology Corporation (PDSB) institutional ownership

Latest close $0.69 Jul 27, 2026
Market cap$54M 52-week range SectorHealthcare
Funds holding · Q1 2026
33
reported PDSB position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
15 buyers · 18 sellers

PDS Biotechnology Corporation (PDSB) price and institutional activity

Dates

Q1 2026

$0 bought by 15 investors
GeodeWells Fargo & Company +13 more
$0 sold by 18 investors
Armistice Capital, LLCUBS Group AG +16 more
Bought Sold Totals per quarter; hover a bar for the names.

PDS Biotechnology Corporation (PDSB) institutional activity · 33

Investor Type Est. change Change Δ Own Date
Armistice Capital, LLC · Reduced
Change −2.7M Date Q1 2026
Armistice Capital, LLC Reduced· Q1 2026 −2.7M Q1 2026
UBS Group AG · Reduced
Change −196K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −196K Q1 2026
Squarepoint Ops LLC · Exited
Change −193K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −193K −100.0% Q1 2026
Geode · Added
Change +140K Date Q1 2026
Geode Added· Q1 2026 +140K Q1 2026
Commonwealth Equity Services, LLC · Reduced
Change −106K Date Q1 2026
Commonwealth Equity Services, LLC Reduced· Q1 2026 −106K Q1 2026
Wells Fargo & Company · Added
Change +105K Date Q1 2026
Wells Fargo & Company Added· Q1 2026 +105K Q1 2026
Nine Masts Capital Ltd · New
Change +68K Date Q1 2026
Nine Masts Capital Ltd New· Q1 2026 +68K Q1 2026
Blair William & Co · Added
Change +50K Date Q1 2026
Blair William & Co Added· Q1 2026 +50K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +44K +25.0% Q1 2026
Northern Trust · Reduced
Change −35K Date Q1 2026
Northern Trust Reduced· Q1 2026 −35K Q1 2026
Virtu Financial LLC · Exited
Change −32K Δ Own −100.0% Date Q1 2026
Virtu Financial LLC Exited· Q1 2026 −32K −100.0% Q1 2026
BlackRock · Added
Change +32K Date Q1 2026
BlackRock Added· Q1 2026 +32K Q1 2026
Two Sigma Securities, LLC · New
Change +31K Date Q1 2026
Two Sigma Securities, LLC New· Q1 2026 +31K Q1 2026
Simplex Trading, LLC · Reduced
Change −19K Date Q1 2026
Simplex Trading, LLC Reduced· Q1 2026 −19K Q1 2026
Susquehanna International Group, LLP · Reduced
Change −17K Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −17K Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 33

Famous investor activity in PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Corporation (PDSB) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Bedu-Addo Frank · Director, Officer Grant (A) 549K
Owned 549K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Bedu-Addo Frank Director, Officer Grant (A) 549K 549K Jan 12, 2026 Mar 3, 2026
Conn Gregory · Officer Grant (A) 150K
Owned 150K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Conn Gregory Officer Grant (A) 150K 150K Jan 12, 2026 Mar 3, 2026
Shepard Kirk V · Officer Grant (A) 300K
Owned 300K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Shepard Kirk V Officer Grant (A) 300K 300K Jan 12, 2026 Mar 3, 2026
Boesgaard Lars · CFO Grant (A) 300K
Owned 300K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Boesgaard Lars CFO Grant (A) 300K 300K Jan 12, 2026 Mar 3, 2026
Brown Spencer D. · Officer Grant (A) 300K
Owned 300K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Brown Spencer D. Officer Grant (A) 300K 300K Jan 12, 2026 Mar 3, 2026
Toutain Stephan · Officer Grant (A) 300K
Owned 300K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Toutain Stephan Officer Grant (A) 300K 300K Jan 12, 2026 Mar 3, 2026
Freitag Gregory Gene · Director Grant (A) 55K
Owned 55K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Freitag Gregory Gene Director Grant (A) 55K 55K Jan 12, 2026 Mar 3, 2026
Iliev Ilian · Director Grant (A) 55K
Owned 55K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Iliev Ilian Director Grant (A) 55K 55K Jan 12, 2026 Mar 3, 2026
Ali-Jackson Kamil · Director Grant (A) 55K
Owned 55K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Ali-Jackson Kamil Director Grant (A) 55K 55K Jan 12, 2026 Mar 3, 2026
Brawley Otis W. · Director Grant (A) 55K
Owned 55K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Brawley Otis W. Director Grant (A) 55K 55K Jan 12, 2026 Mar 3, 2026
Glover Stephen C. · Director Grant (A) 55K
Owned 55K Trade date Jan 12, 2026 Filed date Mar 3, 2026
Glover Stephen C. Director Grant (A) 55K 55K Jan 12, 2026 Mar 3, 2026
11 of 11

PDS Biotechnology Corporation (PDSB) activist and large shareholders

Dates
No Schedule 13D or 13G filing is available for PDSB in this range.

PDS Biotechnology Corporation (PDSB) ownership FAQ

Who owns PDSB?

33 reporting institutions disclosed PDSB position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.